{"product_id":"lysteda-650mg-con-30-tabletas-acido-tranexamico","title":"Lysteda 650Mg With 30 Tablets (Tranexamic Acid)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eMedications for the treatment of bleeding disorders\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eLysteda\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eTranexamic Acid\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003eBox with 30 tablets of 650 mg\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003ePierre Fabre\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eLysteda is indicated for the treatment of bleeding or conditions associated with bleeding, such as: \n    the management of menorrhagia (heavy menstrual bleeding) in women who wish to avoid surgical procedures, \n    as well as in the treatment of post-surgical bleeding and bleeding associated with certain bleeding disorders. \n    Tranexamic acid acts as an antifibrinolytic, inhibiting the premature dissolution of blood clots, \n    which helps to reduce bleeding and the risk of anemia in affected patients. \n    Additionally, it is indicated for the treatment of bleeding in patients with coagulation disorders, \n    as well as in situations of acute bleeding related to trauma or surgery.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Lysteda tablet contains 650 mg of tranexamic acid as the active ingredient. \n    Excipients: microcrystalline cellulose, starch, magnesium stearate, among others.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with a history of deep vein thrombosis, \n    pulmonary embolism, coagulation disorders, severe renal insufficiency, as well as in those who present \n    hypersensitivity to any of the components of the formula.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of thromboembolic events, \n    as well as in those with moderate renal dysfunction. \n    Monitoring of renal function and coagulation is recommended in patients undergoing prolonged treatment. \n    Use in pregnant or breastfeeding women is not recommended without proper medical supervision.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore at room temperature, between 15°C and 30°C, in a dry place protected from direct light. \n    Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e\n\u003cp\u003ePrescription required.\u003c\/p\u003e","brand":"Pierre Fabre","offers":[{"title":"Default Title","offer_id":45848361042145,"sku":"7503000883527","price":1705.84,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/planogram__1__7485ceb3-2609-4b90-aa0c-aee686b1854c.jpg?v=1744682310","url":"https:\/\/wecarepharma.mx\/en\/products\/lysteda-650mg-con-30-tabletas-acido-tranexamico","provider":"WeCare Pharma","version":"1.0","type":"link"}